Lars Wilkinson
Soborg, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Developing a health economic model for Asians with type 2 diabetes based on the Japan Diabetes Complications Study and the Japanese Elderly Diabetes Intervention Trial.
Journal: BMJ open diabetes research & care
Published: February 02, 2021
Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis.
Journal: Advances in therapy
Published: July 22, 2020
Assessing the Impact of Growth Hormone Deficiency (GHD) in Adults: Interpreting Change of the Treatment-Related Impact Measure-Adult Growth Hormone Deficiency (TRIM-AGHD).
Journal: PharmacoEconomics - open
Published: May 26, 2018
Comparative efficacy of once-weekly semaglutide and SGLT-2 inhibitors in type 2 diabetic patients inadequately controlled with metformin monotherapy: a systematic literature review and network meta-analysis.
Journal: Current medical research and opinion
Published: May 17, 2018
A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving Basal Insulin.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: March 16, 2018
A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving 1-2 Oral Anti-Diabetic Drugs.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: March 16, 2018
Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: February 03, 2018
Cost-Effectiveness of rFVIIa versus pd-aPCC in the Management of Mild to Moderate Bleeds in Pediatric Patients with Hemophilia A with Inhibitors in Mexico.
Journal: Value in health regional issues
Published: December 20, 2017
The relationship between target joints and direct resource use in severe haemophilia.
Journal: Health economics review
Published: September 25, 2017
The impact of severe haemophilia and the presence of target joints on health-related quality-of-life.
Journal: Health and quality of life outcomes
Published: August 16, 2017
Understanding Treatment Burden for Children Treated for Growth Hormone Deficiency.
Journal: The patient
Published: April 08, 2017
Last Updated: 09/26/2026